公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 |
2007 | Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes | Chen, K. C.; Cheng, T. L.; Leu, Y. L.; Prijovich, Z. M.; Chuang, C. H.; Chen, B. M.; Roffler, S. R. | Cancer Gene Ther 14(2), 187-200 | | | |
2008 | Membrane-tethered proteins for basic research, imaging and therapy | Cheng, T. L.; Roffler, S. R. | Medicinal Research Reviews 28, 885-928 | | | |
2003 | Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol- modified molecules | Roffler, S. R.; Cheng, T. L.; Wu, P. Y. | US Patent 6,596,849 | | | |
1997 | Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs | Cheng, T. L.; Chen, B. M.; Chan, L. Y.; Wu, P. Y.; Chern, J. W.; Roffler, S. R. | Cancer Immunol Immunother 44, 305-315 | | | |
2001 | Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy | Chen, B. M.; Cheng, T. L.; Tzou, S. C.; Roffler, S. R. | Int J Cancer 94, 850-858 | | | |
2001 | Sensitive measurement of polyethylene glycol-modified proteins | Tsai, N. M.; Cheng, T. L.; Roffler, S. R. | Biotechniques 30, 396-402 | | | |